Celgene Corporation to Present at Investor Conferences in May Robert W. Baird Growth Stock Conference 2014 Bank of America Merrill Lynch 2014 Healthcare Conference UBS Global Life Science Conference 2014 Sanford C. Bernstein Thirtieth Annual Strategic Decisions Conference Business Wire SUMMIT, N.J. -- April 25, 2014 Celgene Corporation (NASDAQ:CELG) announced that Celgene management will provide an overview of the Company at four upcoming investor conferences in the month of May. The conferences will be webcast live and a link to the webcasts will be available in the Investor Relations section of the Company’s website at www.celgene.com. *Wednesday, May 7, 2014 at Baird's 2014 Growth Stock Conference in Chicago at 10:10 a.m. ET *Tuesday, May 13, 2014 at the Bank of America Merrill Lynch Healthcare Conference in Las Vegas at 2:20 p.m. ET *Monday, May 19, 2014 at the UBS Global Life Science Conference in New York at 1:30 p.m. ET *Thursday, May 29, 2014 at the Sanford C. Bernstein Thirtieth Annual Strategic Decisions Conference in New York at 2:00 p.m. ET About Celgene Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit www.celgene.com. Forward-Looking Statements This press release contains forward-looking statements, which are generally statements that are not historical facts. Forward-looking statements can be identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans," "will," “outlook” and similar expressions. Forward-looking statements are based on management’s current plans, estimates, assumptions and projections, and speak only as of the date they are made. We undertake no obligation to update any forward-looking statement in light of new information or future events, except as otherwise required by law. Forward-looking statements involve inherent risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or outcomes may differ materially from those implied by the forward-looking statements as a result of the impact of a number of factors, many of which are discussed in more detail in our Annual Report on Form 10-K and our other reports filed with the Securities and Exchange Commission. Contact: Celgene Corporation Jacqualyn A. Fouse, PhD EVP, Chief Financial Officer 908-673-9956 or Celgene Corporation Patrick E. Flanigan III VP, Investor Relations 908-673-9969
Celgene Corporation to Present at Investor Conferences in May
Press spacebar to pause and continue. Press esc to stop.